Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares hit a new 52-week high during trading on Monday . The company traded as high as C$4.17 and last traded at C$4.15, with a volume of 26439 shares changing hands. The stock had previously closed at C$3.99.
Medexus Pharmaceuticals Stock Down 2.2%
The company has a market capitalization of C$127.91 million, a PE ratio of -198.00 and a beta of 0.57. The stock has a 50-day moving average of C$3.71 and a 200 day moving average of C$3.14.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- The SpaceX IPO Frenzy Is Creating 2 Very Different Bets
- AI Can’t Reach the Real World Without These 3 Stocks
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
